60 Degrees Pharmaceuticals, Inc.
SXTP
$1.63
-$0.08-4.68%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 7.32% | -0.72% | -397.33% | -1,294.74% | -111.03% |
| Total Depreciation and Amortization | 30.14% | 5.62% | -18.07% | -39.10% | -36.49% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -78.52% | -63.22% | 135.10% | 181.98% | 201.12% |
| Change in Net Operating Assets | -102.86% | -85.43% | 108.38% | 181.08% | -52.48% |
| Cash from Operations | -21.27% | -66.80% | -3.60% | -15.83% | -24.32% |
| Capital Expenditure | -34.78% | 62.41% | 56.78% | -84.90% | -80.21% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 122.11% | 193.82% | 60.82% | -8.64% | -2,962.44% |
| Cash from Investing | 113.49% | 183.09% | 58.32% | -44.44% | -1,529.94% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -8.48% | -14.95% | -27.74% | -27.65% | -7.02% |
| Repurchase of Common Stock | -- | 88.03% | 88.03% | 88.03% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -95.80% | -100.00% | -- |
| Cash from Financing | -8.73% | -15.21% | -13.02% | -16.45% | 8.94% |
| Foreign Exchange rate Adjustments | 1,320.00% | -88.54% | -88.94% | -113.80% | -99.19% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 69.07% | -24.68% | -74.94% | -80.56% | -125.73% |